• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Atrial fibrillation as a risk factor for cognitive decline and dementia
ConclusionIn adults aged 45 –85 years AF is associated with accelerated cognitive decline and higher risk of dementia even at ages when AF incidence is low. At least in part, this was explained by incident cardiovascular disease in patients with AF.
Source: European Heart Journal - April 29, 2017 Category: Cardiology Source Type: research

Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study
ConclusionIn this nationwide cohort of AF patients treated with catheter ablation or medical therapy, ablation was associated with decreased dementia risk. This relationship was evident after censoring for stroke and adjusting for clinical confounders.
Source: European Heart Journal - October 6, 2020 Category: Cardiology Source Type: research

Treating hypertension in the very elderly--benefits, risks, and future directions, a focus on the hypertension in the very elderly trial
Although the number of individuals reaching 80 who are considered to be healthy is increasing, the very elderly are likely to have long-term conditions, to report symptoms and/or be taking at least one regular medication. The impact of antihypertensive treatment has to be taken into account in this context. The treatment regimen in Hypertension in the Very Elderly Trial with a goal blood pressure of <150/80 mmHg has been shown to provide benefits in terms of a reduction in risk of total mortality, stroke, and cardiovascular events with potential benefits and no evidence of increased risk for fracture, dementia, depressi...
Source: European Heart Journal - July 7, 2014 Category: Cardiology Authors: Peters, R., Beckett, N., McCormack, T., Fagard, R., Fletcher, A., Bulpitt, C. Tags: Clinical update Source Type: research

Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
ConclusionPrescribing AP monotherapy in newly diagnosed AF has declined, but even nowadays a substantial proportion of AP-treated patients with AF have no indication for AP.Clinical Trial RegistrationURL:http://www.clinicaltrials.gov. Unique identifier: NCT01090362.
Source: European Heart Journal - December 20, 2017 Category: Cardiology Source Type: research

Arrhythmia-associated risk: from cardiac arrest to stroke and dementia
Source: European Heart Journal - December 26, 2020 Category: Cardiology Source Type: research